In our study, we have demonstrated that older patients with HFpEF and AF had lower plasma levels of cardiometabolic (irisin, leptin) and oxidative stress (malondialdehyde) biomarkers, as compared to those without AF. This evidence concerns the gene FNDC5 and atrial fibrillation.